What is the role of mannitol in treating lithium toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the FDA Drug Label

Treatment: ... Urea, mannitol, and aminophylline all produce significant increases in lithium excretion. The role of mannitol in treating lithium toxicity is to increase lithium excretion.

  • Mannitol is used to enhance the elimination of lithium from the body.
  • It is part of the treatment approach for severe lithium poisoning, along with other measures such as gastric lavage, correction of fluid and electrolyte imbalance, and regulation of kidney functioning 1.

From the Research

Mannitol is not recommended as a primary treatment for lithium toxicity, and its use should be cautious and limited to specific cases where hemodialysis is not available or feasible, as evidenced by the lack of strong evidence supporting its effectiveness in reducing morbidity and mortality 2, 3. The role of mannitol in treating lithium toxicity is largely supportive, and its primary mechanism of action is through osmotic diuresis, which can help enhance lithium elimination. However, the evidence supporting the use of mannitol in this context is limited, and it is not considered a first-line treatment for lithium toxicity. Some key points to consider when evaluating the use of mannitol in lithium toxicity include:

  • The primary treatment for severe lithium toxicity remains hemodialysis, which is highly effective in removing circulating lithium and reducing the risk of neurological sequelae 4, 5.
  • Mannitol may be considered as an adjunctive therapy in cases where hemodialysis is not available or feasible, but its use should be cautious and carefully monitored to prevent dehydration or fluid overload 6, 3.
  • The evidence supporting the use of mannitol in lithium toxicity is largely based on observational studies and case reports, and there is a lack of randomized controlled trials to support its effectiveness in reducing morbidity and mortality 2, 3.
  • The use of mannitol should be individualized and based on the specific clinical context, taking into account factors such as the severity of lithium toxicity, renal function, and the presence of other comorbidities 4, 3.

References

Research

Hemodialysis for lithium poisoning.

The Cochrane database of systematic reviews, 2015

Research

Lithium Poisoning.

Journal of intensive care medicine, 2017

Research

Management of lithium toxicity.

Toxicological reviews, 2006

Research

Treatment of acute lithium toxicity.

Veterinary and human toxicology, 1984

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.